Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
    • The Bookshelf
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
    • The Bookshelf
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Diabetes

  • Article

    Bone Biopsy Not Superior to Ulcer-Bed–Biopsy-Guided Antibacterial Therapy on Remission of DFO

    November 2, 2026

    Clinical Question: In patients with diabetic foot osteomyelitis (DFO), is percutaneous bone biopsy superior to ulcer bed biopsy for guiding antimicrobial therapy? Background: Bone biopsy is...

  • Article

    Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

    February 2, 2026

    CLINICAL QUESTION: Does oral semaglutide decrease major cardiovascular events in patients with type 2 diabetes and cardiovascular disease and/or chronic kidney disease? BACKGROUND: Approximately 828...

  • Article

    Optimal Dose of Intranasal Insulin Administration for Reducing Postoperative Delirium Incidence in Older Patients Undergoing Hip Fracture Surgery

    December 1, 2025

    CLINICAL QUESTION: Does intranasal insulin administration reduce postoperative delirium in older patients undergoing hip fracture surgery? BACKGROUND: Cerebral hypometabolism may be a therapeutic...

  • Article

    New Diabetes Medications and Holistic Management

    November 3, 2025

    Nearly one in four hospitalized 12patients in the U.S. has diabetes. These patients have almost twice the hospital readmission rate as those without diabetes, making it a critical area for...

  • Article

    Should We Use Non-Insulin Diabetic Agents on Inpatients?

    November 3, 2025

    Since endocrinologists proved they could name studies equally as well as cardiologists with the RABBIT 2 and NICE SUGAR trials, guidelines have recommended the use of insulin for inpatients with...

  • Article

    SGLT-2 Inhibitors’ Increased Risk of PAD-Related Surgical Events Compared to DPP-4 Inhibitors’ Risk When Used as Add-On Therapy in Diabetes

    October 1, 2025

    CLINICAL QUESTION: Do sodium-glucose cotransporter-2 (SGLT-2) inhibitors, as add-on therapy for diabetes, increase the risk of amputations, stent placement, or revascularization surgeries compared...

  • Article

    Managing Inpatient Diabetes: Practical Pearls and Complex Scenarios

    July 1, 2025

    In this high-yield session, Lily Ackermann, MD, a clinical associate professor of medicine at Thomas Jefferson University Hospital in Philadelphia, addressed the complexities of inpatient diabetes...

  • Article

    Effects of Semaglutide on CKD in Patients with Type 2 Diabetes: the FLOW Trial

    April 1, 2025

    Clinical question: Does treatment with semaglutide in patients with type 2 diabetes and chronic kidney disease (CKD) prevent the progression of CKD or death from kidney and cardiovascular...

  • Article

    There is a Decreased Risk of Hospitalization from Heart Failure in Type II Diabetics Initiated on a SGLT2 Inhibitor When Compared to a GLP-1 Receptor Agonist

    September 1, 2022

    Dr. Huang Clinical question: Determine the cardiovascular risk outcome in type II diabetic patients initiated on an sodium-glucose cotransporter-2 (SGLT2)  inhibitor versus a glucagon-like...

  • Article

    Many hospitalized patients with type 2 diabetes and mild hyperglycemia on admission can be managed with sliding scale insulin alone

    January 7, 2022

    Dr. Knees Clinical question: In patients with mild hyperglycemia on admission, can sliding scale insulin (SSI) alone be used for blood glucose (BG) control? Background: Prior randomized...

1 2 3 … 15Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences